Guilin Layn Natural Ingredients Corp. (SHE:002166)
China · Delayed Price · Currency is CNY 8.91
+0.13 (1.48%)
May 6, 2026, 3:04 PM CST
SHE:002166 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,970 | 1,967 | 1,725 | 1,484 | 1,322 | 1,006 |
Other Revenue | 76.82 | 76.82 | 46.5 | 9.83 | 78.78 | 46.89 |
| 2,046 | 2,044 | 1,772 | 1,494 | 1,401 | 1,053 | |
Revenue Growth (YoY) | 9.15% | 15.36% | 18.60% | 6.65% | 32.99% | 34.40% |
Cost of Revenue | 1,520 | 1,526 | 1,272 | 1,166 | 992.68 | 748.76 |
Gross Profit | 526.08 | 517.93 | 499.77 | 327.72 | 408.05 | 304.47 |
Selling, General & Admin | 226.35 | 221.73 | 202.63 | 192.78 | 148.63 | 121.66 |
Research & Development | 53.55 | 58.35 | 57.5 | 48.39 | 44.26 | 38.98 |
Other Operating Expenses | 9.36 | 12.05 | 6.68 | 8.38 | 5.82 | 5.36 |
Operating Expenses | 294.32 | 297.2 | 285.3 | 252.75 | 199.01 | 166.96 |
Operating Income | 231.76 | 220.73 | 214.47 | 74.97 | 209.04 | 137.52 |
Interest Expense | -43 | -43 | -42.24 | -32.9 | -27.72 | -24.65 |
Interest & Investment Income | 7.54 | 7.49 | 11.41 | 12.72 | 12.79 | 6.73 |
Currency Exchange Gain (Loss) | 0.83 | 0.83 | 8.76 | 1.56 | 10.47 | -3 |
Other Non Operating Income (Expenses) | -10.69 | -6.36 | -2.79 | 5.41 | -1.21 | -0.64 |
EBT Excluding Unusual Items | 186.43 | 179.68 | 189.61 | 61.77 | 203.37 | 115.96 |
Gain (Loss) on Sale of Investments | 9.05 | 4.25 | 2.03 | 45.35 | 35.63 | 12.54 |
Gain (Loss) on Sale of Assets | 0.37 | -0.13 | -0.52 | -0.71 | -0.08 | -0.81 |
Asset Writedown | -3.21 | -3.36 | -1.12 | -8.05 | -0.02 | - |
Other Unusual Items | 20.27 | 20.27 | 17.85 | 18.01 | -0.56 | 24.24 |
Pretax Income | 212.9 | 200.7 | 207.84 | 116.36 | 238.34 | 151.94 |
Income Tax Expense | 50.04 | 47.82 | 40.66 | 18.02 | 50.04 | 20.75 |
Earnings From Continuing Operations | 162.85 | 152.88 | 167.17 | 98.35 | 188.29 | 131.19 |
Minority Interest in Earnings | -8.01 | -9.76 | -4.17 | -15.84 | -9.55 | -12.75 |
Net Income | 154.85 | 143.12 | 163.01 | 82.51 | 178.74 | 118.44 |
Net Income to Common | 154.85 | 143.12 | 163.01 | 82.51 | 178.74 | 118.44 |
Net Income Growth | -7.29% | -12.20% | 97.56% | -53.84% | 50.91% | 37.74% |
Shares Outstanding (Basic) | 737 | 736 | 729 | 750 | 616 | 564 |
Shares Outstanding (Diluted) | 737 | 736 | 729 | 750 | 616 | 564 |
Shares Change (YoY) | -1.11% | 0.98% | -2.85% | 21.70% | 9.28% | -1.62% |
EPS (Basic) | 0.21 | 0.19 | 0.22 | 0.11 | 0.29 | 0.21 |
EPS (Diluted) | 0.21 | 0.19 | 0.22 | 0.11 | 0.29 | 0.21 |
EPS Growth | -6.25% | -13.05% | 103.36% | -62.07% | 38.09% | 40.00% |
Free Cash Flow | 142.8 | -1.95 | -47.37 | -313.37 | -377.38 | -152.58 |
Free Cash Flow Per Share | 0.19 | -0.00 | -0.07 | -0.42 | -0.61 | -0.27 |
Dividend Per Share | 0.100 | 0.100 | 0.100 | 0.200 | 0.100 | - |
Dividend Growth | - | - | -50.00% | 100.00% | - | - |
Gross Margin | 25.71% | 25.34% | 28.21% | 21.94% | 29.13% | 28.91% |
Operating Margin | 11.33% | 10.80% | 12.11% | 5.02% | 14.92% | 13.06% |
Profit Margin | 7.57% | 7.00% | 9.20% | 5.52% | 12.76% | 11.24% |
Free Cash Flow Margin | 6.98% | -0.10% | -2.67% | -20.98% | -26.94% | -14.49% |
EBITDA | 366.41 | 348.21 | 313.26 | 159.95 | 280.52 | 192.93 |
EBITDA Margin | 17.90% | 17.04% | 17.68% | 10.71% | 20.03% | 18.32% |
D&A For EBITDA | 134.65 | 127.48 | 98.79 | 84.98 | 71.47 | 55.41 |
EBIT | 231.76 | 220.73 | 214.47 | 74.97 | 209.04 | 137.52 |
EBIT Margin | 11.33% | 10.80% | 12.11% | 5.02% | 14.92% | 13.06% |
Effective Tax Rate | 23.51% | 23.82% | 19.56% | 15.48% | 21.00% | 13.66% |
Revenue as Reported | 2,044 | 2,044 | 1,772 | 1,494 | 1,401 | 1,053 |
Advertising Expenses | - | 9.73 | 8.77 | 6.53 | 6.09 | 4.08 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.